Key Financials | KlickAnalytics

23.24 0.24(1.04%)05/20/2024
Silence Therapeutics Plc (SLN)

(Values in GBP Thousands)

	2023-09-30	2023-06-30	2023-03-31	2022-12-31	2022-09-30	2022-06-30	2022-03-31	2021-12-31
Net Income	-8,250	-10,401	-10,204	-13,763
Revenue	2,798	9,104	11,374	4,765
Cost Of Revenue	1,607	2,831	4,534	3,859
gross Profit	1,191	6,273	6,840	906
Operating Expenses	13,890	17,730	18,989	11,867
Selling General and Administrative Expenses	4,956	5,115	6,450	3,468
Research and Development Expenses	8,934	12,615	12,539	8,399
Cost And Expenses	15,497	20,561	23,523	15,726
Operating Income	-12,699	-11,457	-12,149	-10,961
Interest Income	2,046	340	336	-5,122
Income Tax Expense	-2,411	-1,609	-2,469	-1,287
Income Before Tax	-10,661	-12,010	-12,673	-15,050
Earning Per Share Basic	-0.22	-0.29	-0.28	-0.43
Earning Per Share Diluted	-0.22	-0.29	-0.28	-0.43
weighted Average Shares Outstanding	37,305	36,163	35,981	32,195
weighted Average Shares Outstanding (Diluted)	37,305	36,163	35,981	32,195
Gross Margin	0.43	0.69	0.60	0.19
EBIT Margin	-3.76	-1.21	-1.03	-3.13
Profit Margin	-2.95	-1.14	-0.90	-2.89
EBITDA	-10,528	-10,999	-11,679	-14,896
Earning Before Tax Margin	-3.81	-1.32	-1.11	-3.16